↓ Skip to main content

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
95 Mendeley